Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.
scientific article published on 25 July 2014
Author/s
author: Niels Vande Casteele, Séverine Vermeire, David Drobne, Peter Bossuyt, Christine Breynaert, Kristel Van Steen, Paul Rutgeerts, Isabelle Cleynen, Willem-Jan Wollants, Griet Compernolle
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.